Glaxosmithkline Pharmaceuticals Ltd Board of Directors
Board of Directors at Glaxosmithkline Pharmaceuticals Ltd
A Nadkarni
Company Sec. & Compli. Officer
A Roy
Independent Director
Bhushan Akshikar
Managing Director
D Sundaram
Independent Director
J. Chandy
Whole Time Director & CFO
Key Highlights
- Renu S. Karnad joins the board as Chairman & Non Executive Dir., in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Bhushan Akshikar continues to serve as the Managing Director in 2026, maintaining the same position as in the previous year.
- Manu Anand joins the board as Independent Non Exe. Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Sunita Maheshwari joins the board as Independent Non Exe. Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Somasundaram Palamadairamaswamy joins the board as Independent Non Exe. Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Glaxosmithkline Pharmaceuticals Ltd
NSE: GLAXO
Share Price
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 06 Oct 2026 | 2758.1 |
| 05 Oct 2026 | 2734.25 |
| 01 Oct 2026 | 2774.5 |
| 30 Sep 2026 | 2767.6 |
| 29 Sep 2026 | 2787.25 |
| 28 Sep 2026 | 2897.85 |
| 25 Sep 2026 | 2816.85 |
| 24 Sep 2026 | 2825.75 |
| 23 Sep 2026 | 2876.5 |
| 22 Sep 2026 | 2871.5 |
Company Fundamentals for Glaxosmithkline Pharmaceuticals Ltd
Market Cap
46,723 Cr
EPS
62.2
P/E Ratio (TTM)
44.4
P/B Ratio (TTM)
20.6
Day’s High
2764.0
Day’s Low
2709.0
DTE
0.0
ROE
45.7
52 Week High
3121.1
52 Week Low
2088.0
ROCE
61.2
Market Price of Glaxosmithkline Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Monitoring Glaxosmithkline Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
Glaxosmithkline Pharmaceuticals Ltd News Hub
Glaxosmithkline Pharmaceuticals consolidated net profit rises 37.87% in the June 2024 quarter
Net profit of Glaxosmithkline Pharmaceuticals rose 37.87% to Rs 182.33 crore in the quarter ended Ju
Read more
05 Aug 24
GSK Pharma Q1 PAT climbs 39% YoY to Rs 182 crore
Revenue from operations grew by 9.89% year on year (YoY) to Rs 811 crore during the quarter ended Ju
Read more
03 Aug 24
GlaxoSmithKline Pharmaceuticals to conduct board meeting
GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 M
Read more
19 Apr 25
GlaxoSmithKline Pharmaceuticals to declare Quarterly Result
GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 O
Read more
25 Oct 24
Document
Annual Reports
Annual Report 2024
Credit Ratings
N/A
Concalls
Popular Search
FAQs for Board of Directors of Glaxosmithkline Pharmaceuticals Ltd
How are members of Glaxosmithkline Pharmaceuticals Ltd Board of Directors selected?
Members of the Glaxosmithkline Pharmaceuticals Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Glaxosmithkline Pharmaceuticals Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.
Can shareholders interact with the Glaxosmithkline Pharmaceuticals Ltd Board of Directors?
Shareholders can interact with the Glaxosmithkline Pharmaceuticals Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.
How often does the Glaxosmithkline Pharmaceuticals Ltd Board of Directors meet?
The Glaxosmithkline Pharmaceuticals Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.
What are the responsibilities of the Glaxosmithkline Pharmaceuticals Ltd Board of Directors?
The Glaxosmithkline Pharmaceuticals Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.
Who are the current members of the Board of Directors at Glaxosmithkline Pharmaceuticals Ltd?
The current Board of Directors at Glaxosmithkline Pharmaceuticals Ltd includes Renu S. Karnad( Chairman & Non Executive Dir.) ,Bhushan Akshikar( Managing Director) ,Manu Anand( Independent Non Exe. Director) ,Sunita Maheshwari( Independent Non Exe. Director) ,Somasundaram Palamadairamaswamy( Independent Non Exe. Director) . The full list can be found on Glaxosmithkline Pharmaceuticals Ltd’s official website or recent corporate filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
